PHARMACOKINETICS AND METABOLIC EFFECTS OF GLIBENCLAMIDE AND GLIPIZIDE IN TYPE-2 DIABETICS

被引：58

作者：

GROOP, L

WAHLINBOLL, E

GROOP, PH

TOTTERMAN, KJ

MELANDER, A

TOLPPANEN, EM

FYHRQVIST, F

机构：

[1] UNIV HELSINKI,DEPT MED 3,SF-00170 HELSINKI 17,FINLAND

[2] UNIV HELSINKI,DEPT MED 4,SF-00170 HELSINKI 17,FINLAND

[3] LUND UNIV,HLTH SCI CTR,DIV CLIN PHARMACOL,DALBY,SWEDEN

来源：

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY | 1985年 / 28卷 / 06期

关键词：

D O I：

10.1007/BF00607919

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：697 / 704

页数：8

共 35 条

[31] IMPAIRED EFFECT OF SULFONYLUREA FOLLOWING INCREASED DOSAGE [J].

WAHLINBOLL, E ;

SARTOR, G ;

MELANDER, A ;

SCHERSTEN, B .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1982, 22 (01) :21-25

[32] HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC DETERMINATION OF GLIPIZIDE AND SOME OTHER SULFONYLUREA DRUGS IN SERUM [J].

WAHLINBOLL, E ;

MELANDER, A .

JOURNAL OF CHROMATOGRAPHY, 1979, 164 (04) :541-546

[33] INFLUENCE OF FOOD-INTAKE ON THE ABSORPTION AND EFFECT OF GLIPIZIDE IN DIABETICS AND IN HEALTHY-SUBJECTS [J].

WAHLINBOLL, E ;

MELANDER, A ;

SARTOR, G ;

SCHERSTEN, B .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1980, 18 (03) :279-283

[34] BIOAVAILABILITY, PHARMACOKINETICS AND EFFECTS OF GLIPIZIDE IN TYPE-2 DIABETICS [J].

WAHLINBOLL, E ;

ALMER, LO ;

MELANDER, A .

CLINICAL PHARMACOKINETICS, 1982, 7 (04) :363-372

[35] EXTRAPANCREATIC EFFECT OF GLIBENCLAMIDE - STIMULATION OF DUODENAL INSULIN-RELEASING ACTIVITY (DIRA) IN MAN [J].

ZERMATTEN, A ;

HEPTNER, W ;

DELALOYE, B ;

SECHAUD, R ;

FELBER, JP .

DIABETOLOGIA, 1977, 13 (02) :85-88

← 1 2 3 4 →